Chemoinformaics analysis of 1,2-Cyclohexanedione
| Molecular Weight | 112.128 | nRot | 0 |
| Heavy Atom Molecular Weight | 104.064 | nRig | 8 |
| Exact Molecular Weight | 112.052 | nRing | 1 |
| Solubility: LogS | -1.467 | nHRing | 0 |
| Solubility: LogP | 0.467 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.9583 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.432 |
| Synth | 2.18 |
| Natural Product Likeliness | 0.038 |
| NR-PPAR-gamma | 0.238 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.746 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.506 |
| MDCK | 0.0000324 |
| BBB | 0.995 |
| PPB | 0.47758 |
| VDSS | 0.337 |
| FU | 0.672059 |
| CYP1A2-inh | 0.314 |
| CYP1A2-sub | 0.512 |
| CYP2c19-inh | 0.11 |
| CYP2c19-sub | 0.338 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.455 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.223 |
| CL | 7.773 |
| T12 | 0.752 |
| hERG | 0.022 |
| Ames | 0.876 |
| ROA | 0.569 |
| SkinSen | 0.896 |
| Carcinogencity | 0.519 |
| EI | 0.991 |
| Respiratory | 0.549 |
| NR-Aromatase | 0.054 |
| Antiviral | No |
| Prediction | 0.943861 |